MTOR and cancer: mTOR activity can also be affected by complex I; [15] and the Akt/mTOR signaling pathway is an upstream regulator of proliferation, EMT and cancer metastasis.[23–27] Therefore, we investigated if the Akt/mTOR signaling pathway is activated by loss of NDUFB9 in MDA-MB-231 cells.